Previous 10 | Next 10 |
STAAR Surgical Company (STAA) Q3 2020 Earnings Conference Call November 4, 2020 4:30 p.m. ET Company Participants Brian Moore - VP, Investor, Media Relations and Corporate Development Caren Mason - President and CEO Patrick Williams - CFO Conference Call Participants Anthony Petrone - Jefferi...
STAAR Surgical Company (STAA) Q3 2020 Earnings Conference Call October 4, 2020 4:20 PM ET Company Participants Brian Moore - VP, Investor, Media Relations & Corporate Development Caren Mason - President and Chief Executive Officer Patrick Williams - Chief Financial Officer Conference Call...
STAAR Surgical (STAA): Q3 Non-GAAP EPS of $0.14 beats by $0.05; GAAP EPS of $0.08 beats by $0.05.Revenue of $47.08M (+20.5% Y/Y) beats by $4.09M.Shares +2.45%.Press Release For further details see: STAAR Surgical EPS beats by $0.05, beats on revenue
Innovative EVO Viva Implantable Collamer® Lens Corrects Near, Intermediate and Distance Vision STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced the ini...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the third quarter ended October 2, 2020. Third Quarter 2020 Overview Record Quar...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the third quarter ended October 2, 2020 on Wednesday, November 4...
New York, New York--(Newsfile Corp. - October 16, 2020) - Faruqi & Faruqi, LLP, a leading minority and certified woman-owned national securities law firm, is investigating claims against STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ:STAA) and reminds investors of the Octo...
San Francisco, California--(Newsfile Corp. - October 11, 2020) - Hagens Berman urges STAAR Surgical Company (NASDAQ: STAA) investors to contact the firm now . A securities fraud class action has been filed and certain investors may have valuable claims. Class Period: Feb. 26, 2020 - Aug....
New York, New York--(Newsfile Corp. - October 8, 2020) - Faruqi & Faruqi, LLP, a leading minority and certified woman-owned national securities law firm, is investigating claims against STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) and reminds investors of the October 19...
San Francisco, California--(Newsfile Corp. - October 8, 2020) - Hagens Berman urges STAAR Surgical Company (NASDAQ: STAA) investors to contact the firm now . A securities fraud class action has been filed and certain investors may have valuable claims. Class Period: Feb. 26, 2020 - Au...
News, Short Squeeze, Breakout and More Instantly...
STAAR Surgical Company Company Name:
STAA Stock Symbol:
NASDAQ Market:
STAAR Surgical Company Website:
2024-07-14 17:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, invites investors and the general public to listen to a webcast fireside chat with Patrick F. Will...
2024-05-24 07:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...